The unreliability of indirect lung compliance in healthy subjects and patients with chronic lung disorders. 1981

A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin

The clinical usefulness of lung compliance calculated indirectly was reassessed in a large number of healthy subjects and patients with chronic airflow obstruction or restrictive lung disorders. Indirect compliance was calculated from maximal expiratory flow-volume (MEFV) curve and airway resistance measured plethysmographically according to two approaches. In the first (approach A) all calculations were done at the functional residual capacity, whereas in the second (approach B) they were obtained over the 50-75% volume range of the forced vital capacity; values were compared to those of direct compliance measured concurrently. For the group as a whole, the correlations between indirect and direct values were poor regardless of the approach. Examined separately, the best correlations were found for the healthy group using approach A (r = 0.501) and for the obstructive group using approach B (r = 0.312). Failure to derive a valuable indirect compliance is due to the fact that there is a very poor correlation between upstream resistance and airway resistance measured by body plethysmography.U

UI MeSH Term Description Entries
D008170 Lung Compliance The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p562) Compliance, Lung,Compliances, Lung,Lung Compliances
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008173 Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. Obstructive Lung Diseases,Obstructive Pulmonary Diseases,Lung Disease, Obstructive,Obstructive Lung Disease,Obstructive Pulmonary Disease,Pulmonary Disease, Obstructive,Pulmonary Diseases, Obstructive
D008449 Maximal Expiratory Flow-Volume Curves Curves depicting MAXIMAL EXPIRATORY FLOW RATE, in liters/second, versus lung inflation, in liters or percentage of lung capacity, during a FORCED VITAL CAPACITY determination. Common abbreviation is MEFV. Maximal Expiratory Flow Volume Curves
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010993 Plethysmography, Whole Body Measurement of the volume of gas in the lungs, including that which is trapped in poorly communicating air spaces. It is of particular use in chronic obstructive pulmonary disease and emphysema. (Segen, Dictionary of Modern Medicine, 1992) Whole Body Plethysmography,Body Plethysmographies, Whole,Body Plethysmography, Whole,Plethysmographies, Whole Body,Whole Body Plethysmographies
D005652 Functional Residual Capacity The volume of air remaining in the LUNGS at the end of a normal, quiet expiration. It is the sum of the RESIDUAL VOLUME and the EXPIRATORY RESERVE VOLUME. Common abbreviation is FRC. Capacities, Functional Residual,Capacity, Functional Residual,Functional Residual Capacities,Residual Capacities, Functional,Residual Capacity, Functional
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000403 Airway Resistance Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow. Airway Resistances,Resistance, Airway,Resistances, Airway

Related Publications

A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
January 1978, Respiration; international review of thoracic diseases,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
June 1959, The Yale journal of biology and medicine,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
December 1980, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
October 2007, Journal of clinical pharmacology,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
August 2012, International angiology : a journal of the International Union of Angiology,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
December 2011, Phlebology,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
October 1974, Archives of environmental health,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
January 2023, Frontiers in neurology,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
April 1981, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
A B Bohadana, and J M Jansen da Silva, and B Hannhart, and R Peslin
January 1981, Respiration; international review of thoracic diseases,
Copied contents to your clipboard!